Skip to main content
Log in

Association between Serum Magnesium Levels and Risk of Dyslipidemia: A Cross-Sectional Study from the China Health and Nutrition Survey

  • Research
  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

A growing number of observational studies have been carried out on the relationship between serum magnesium and risk of dyslipidemia, but their results were conflicting. This study aimed to investigate the association between serum magnesium levels and risk of dyslipidemia in Chinese adult residents. We used data from the China Health and Nutrition Survey (CHNS) in the wave of 2009 to conduct a cross-sectional study. A total of 8,457 participants (47.2% male) with a mean age of 50.5 years were assessed and divided into 4 groups based on quartiles of serum magnesium levels. We found that higher quartiles of serum magnesium were associated with increased prevalence of dyslipidemia. After adjustment for confounders, the results of logistic regression analyses indicated that there was an increased trend in dyslipidemia risk as quartiles of serum magnesium increased. The restricted cubic spline model revealed a nonlinear relationship between serum magnesium levels and dyslipidemia. In subgroup analyses, the positive relationship between serum magnesium levels and dyslipidemia was more significant in females than in males. Our study suggested that serum magnesium levels were positively associated with risk of dyslipidemia in Chinese adult population. Further research is needed to provide a deep understanding of the underlying mechanism of magnesium on lipid metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data Availability

The datasets generated during and/or analyzed during the current study are available at the website (http://www.cpc.unc.edu/projects/china/home.html).

References

  1. Pirillo A, Casula M, Olmastroni E, Norata G-D, Catapano A-L (2021) Global epidemiology of dyslipidaemias. Nat Rev Cardiol 18:689–700

    Article  CAS  PubMed  Google Scholar 

  2. Ference B-A, Graham I, Tokgozoglu L, Catapano A-L (2018) Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series. J Am Coll Cardiol 72:1141–1156

    Article  CAS  PubMed  Google Scholar 

  3. Mehta A, Shapiro M-D (2022) Apolipoproteins in vascular biology and atherosclerotic disease. Nat Rev Cardiol 19:168–179

    Article  CAS  PubMed  Google Scholar 

  4. National Health Commission Bureau for Disease Control and Prevention. Report on Chinese Nutrition and Chronic Diseases (2020) National Health Commission Bureau for Disease Control and Prevention. Beijing, China, p 5

  5. Opoku S, Gan Y, Yobo E-A, Tenkorang-Twum D, Yue W, Wang Z, Lu Z et al (2021) Awareness, treatment, control, and determinants of dyslipidemia among adults in China. Sci Rep 11:10056

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Fiorentini D, Cappadone C, Farruggia G, Prata C (2021) Magnesium: biochemistry, nutrition, detection, and social impact of diseases linked to its deficiency. Nutrients 13(4):1136

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Elin R-J (1988) Magnesium metabolism in health and disease. Dis Mon 34:161–218

    Article  CAS  PubMed  Google Scholar 

  8. Zhang Q, Zhou P-H, Zhou X-L, Zhang D-L, Gu Q, Zhang S-J, Qian Z-Y et al (2018) Effect of magnesium gluconate administration on lipid metabolism, antioxidative status, and related gene expression in rats fed a high-fat diet. Magnes Res 31:117–130

    CAS  PubMed  Google Scholar 

  9. Chen S, Luo S, Zou B, Xie J, Li J, Zeng Y et al (2023) Magnesium supplementation stimulates autophagy to reduce lipid accumulation in hepatocytes via the AMPK/mTOR pathway. Biol Trace Elem Res 201:3311–3322

    Article  CAS  PubMed  Google Scholar 

  10. Kurstjens S, van Diepen J-A, Overmars-Bos C, Alkema W, Bindels RJM, Ashcroft F-M, de Baaij JHF et al (2018) Magnesium deficiency prevents high-fat-diet-induced obesity in mice. Diabetologia 61:2030–2042

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Găman M-A, Dobrică E-C, Cozma M-A, Antonie N-I, Stănescu AMA, Găman A-M, Diaconu C-C et al (2021) Crosstalk of magnesium and serum lipids in dyslipidemia and associated disorders: a systematic review. Nutrients 13(5):1411

    Article  PubMed  PubMed Central  Google Scholar 

  12. Zhao S-P (2016) [Key points and comments on the 2016 Chinese guideline for the management of dyslipidemia in adults]. Zhonghua Xin Xue Guan Bing Za Zhi 44:827–829

    CAS  PubMed  Google Scholar 

  13. Randell E-W, Mathews M, Gadag V, Zhang H, Sun G (2008) Relationship between serum magnesium values, lipids and anthropometric risk factors. Atherosclerosis 196:413–419

    Article  CAS  PubMed  Google Scholar 

  14. Cao Y, Wang C, Guan K, Xu Y, Su Y-X, Chen Y-M et al (2016) Association of magnesium in serum and urine with carotid intima-media thickness and serum lipids in middle-aged and elderly Chinese: a community-based cross-sectional study. Eur J Nutr 55:219–26

    Article  CAS  PubMed  Google Scholar 

  15. Liu A, Xu P, Gong C, Zhu Y, Zhang H, Nie W, Zhou J-C et al (2020) High serum concentration of selenium, but not calcium, cobalt, copper, iron, and magnesium, increased the risk of both hyperglycemia and dyslipidemia in adults: A health examination center based cross-sectional study. J Trace Elem Med Biol 59:126470

    Article  CAS  PubMed  Google Scholar 

  16. Alkazemi D, Alsouri N, Zafar T, Kubow S (2022) Hypomagnesemia and the metabolic syndrome among apparently healthy Kuwaiti adults: a cross-sectional study. Nutrients 14(24):5257

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Corica F, Corsonello A, Ientile R, Cucinotta D, Di Benedetto A, Perticone F, Barbagallo M et al (2006) Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J Am Coll Nutr 25:210–5

    Article  CAS  PubMed  Google Scholar 

  18. Barragán R, Llopis J, Portolés O, Sorlí J-V, Coltell O, Rivas-García L, Sánchez-González C et al (2020) Influence of demographic and lifestyle variables on plasma magnesium concentrations and their associations with cardiovascular risk factors in a Mediterranean population. Nutrients 12(4):1018

    Article  PubMed  PubMed Central  Google Scholar 

  19. Liu M, Dudley SC-Jr, (2020) Magnesium, oxidative stress, inflammation, and cardiovascular disease. Antioxidants (Basel) 9(10):907

    Article  CAS  PubMed  Google Scholar 

  20. Oost L-J, Tack C-J, de Baaij JHF (2023) Hypomagnesemia and cardiovascular risk in Type 2 diabetes. Endocr Rev 44:357–378

    Article  PubMed  Google Scholar 

  21. Rooney M-R, Alonso A, Folsom A-R, Michos E-D, Rebholz C-M, Misialek J-R, Lutsey P-L et al (2020) Serum magnesium and the incidence of coronary artery disease over a median 27 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study and a meta-analysis. Am J Clin Nutr 111:52–60

    Article  PubMed  Google Scholar 

  22. Song Y, He K, Levitan E-B, Manson J-E, Liu S (2006) Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med 23:1050–6

    Article  CAS  PubMed  Google Scholar 

  23. Salehidoost R, Taghipour Boroujeni G, Feizi A, Aminorroaya A, Amini M (2022) Effect of oral magnesium supplement on cardiometabolic markers in people with prediabetes: a double blind randomized controlled clinical trial. Sci Rep 12:18209

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Sadeghian M, Azadbakht L, Khalili N, Mortazavi M, Esmaillzadeh A (2020) Oral magnesium supplementation improved lipid profile but increased insulin resistance in patients with diabetic nephropathy: a double-blind randomized controlled clinical trial. Biol Trace Elem Res 193:23–35

    Article  CAS  PubMed  Google Scholar 

  25. Nartea R, Mitoiu B-I, Ghiorghiu I (2023) The link between magnesium supplements and statin medication in dyslipidemic patients. Curr Issues Mol Biol 45:3146–3167

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Schutten J-C, Joris P-J, Groendijk I, Eelderink C, Groothof D, van der Veen Y, Bakker SJL et al (2022) Effects of magnesium citrate, magnesium oxide, and magnesium sulfate supplementation on arterial stiffness: a randomized, double-blind, placebo-controlled intervention trial. J Am Heart Assoc 11:e021783

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Bressendorff I, Hansen D, Schou M, Kragelund C, Svensson M, Hashemi B, Brandi L et al (2023) The effect of magnesium supplementation on vascular calcification in CKD: a randomized clinical trial (MAGiCAL-CKD). J Am Soc Nephrol 34:886–894

    Article  PubMed  Google Scholar 

  28. Rosanoff A, West C, Elin R-J, Micke O, Baniasadi S, Barbagallo M, Wolf F et al (2022) Recommendation on an updated standardization of serum magnesium reference ranges. Eur J Nutr 61:3697–3706

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Costello R-B, Elin R-J, Rosanoff A, Wallace T-C, Guerrero-Romero F, Hruby A, Van Horn L-V et al (2016) Perspective: the case for an evidence-based reference interval for serum magnesium: the time has come. Adv Nutr 7:977–993

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Rosanoff A, Seelig M-S (2004) Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals. J Am Coll Nutr 23:501S-505S

    Article  CAS  PubMed  Google Scholar 

  31. Rosner M-H, Ha N, Palmer B-F, Perazella M-A (2023) Acquired disorders of hypomagnesemia. Mayo Clin Proc 98:581–596

    Article  CAS  PubMed  Google Scholar 

  32. Huijgen H-J, Soesan M, Sanders R, Mairuhu W-M, Kesecioglu J, Sanders G-T et al (2000) Magnesium levels in critically ill patients. What should we measure? Am J Clin Pathol 114:688–695

    Article  CAS  PubMed  Google Scholar 

  33. Casal H-L, Mantsch H-H, Hauser H (1989) Infrared and 31P-NMR studies of the interaction of Mg2+ with phosphatidylserines: effect of hydrocarbon chain unsaturation. Biochim Biophys Acta 982:228–36

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to express sincere appreciation to the Institutional Review Board of the University of North Carolina at Chapel Hill and the National Institute for Nutrition and Food safety at China Center for Disease Control and Prevention for providing original data publicly available.

Author information

Authors and Affiliations

Authors

Contributions

Both Yang Liu and Shizhen Li contributed to the design, methodology, interpretation, and writing of the paper. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Shizhen Li.

Ethics declarations

Competing Interests

The authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Y., Li, S. Association between Serum Magnesium Levels and Risk of Dyslipidemia: A Cross-Sectional Study from the China Health and Nutrition Survey. Biol Trace Elem Res 202, 2410–2418 (2024). https://doi.org/10.1007/s12011-023-03846-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-023-03846-2

Keywords

Navigation